scAmp analyzes focal gene amplifications at single-cell resolution
Jones, M. G.; Weiser, N. E.; Hung, K. L.; Yan, X.; Agarwal, S.; Luebeck, J.; Gnanasekar, A.; Howitt, B. E.; Curtis, E. J.; Yu, K.; Rose, J. C.; Kraft, K.; Amiri, V. V. P.; Satpathy, L.; Bafna, V.; Mischel, P. S.; Chang, H. Y.
Show abstract
Oncogene amplification on extrachromosomal DNA (ecDNA) is a common driver of tumor progression and is associated with acquired drug resistance and poor patient survival. While whole genome sequencing (WGS) studies have revealed the landscape of genes amplified on ecDNA in tumors, it remains challenging to study the subclonal heterogeneity and functional (e.g., transcriptomic) consequences of ecDNA on tumors. To address this, we introduce scAmp: a probabilistic algorithm for detecting and analyzing ecDNA from single-cell datasets. We demonstrate scAmps improved accuracy over WGS approaches on well-characterized cell-lines and its applicability to clinical histopathology. We further showcase scAmp by analyzing 73 patient tumors profiled with single-cell ATAC-seq, where we analyze the subclonal evolution of ecDNA+ subclones and identify the effect of ecDNA amplifications on the chromatin accessibility landscape of cancer cells. Together, we anticipate that scAmp will broadly enable further studies - both retrospective and prospective - that dissect critical questions of how ecDNA affect cancer cells and the tumors in which they reside.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Achieving single nucleotide sensitivity in direct hybridization genome imaging 99%
- High-throughput single-cell chromatin accessibility CRISPR screens enable unbiased identification of regulatory networks in cancer 99%
- CTCF and transcription influence chromatin structure re-configuration after mitosis 98%
Similar papers in this journal
- Extracellular 2’3’-cGAMP is an immunotransmitter produced by cancer cells and regulated by ENPP1 97%
- Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response 97%
- The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1 97%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.